Key facts
- Morgan Stanley raised its price target for Philip Morris (PM).
- The firm cited growing confidence in Zyn and IQOS product lines.
Morgan Stanley has increased its price target for Philip Morris (PM) due to growing confidence in the company's Zyn and IQOS product lines. This adjustment reflects a positive outlook on the future growth potential of these key Philip Morris offerings.